Search
Second Dose of Palonosetron Reduces CINV in Pediatric Cancer Patients
- OPACC
- Oct 19, 2023
- 1 min read
An additional dose of palonosetron can help prevent chemotherapy-induced nausea and vomiting (CINV) in children with cancer who are receiving multiple-day moderately or highly emetogenic chemotherapy, a randomized study suggests.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Comments